MiR-34a in hBMSC-derived exosomes inhibits glioblastoma cell proliferation, migration, invasion and tumorigenesis in vitro and in vivo and promotes chemosensitivity to temozolomide by suppressing MYCN [34]. The gene discussed is MYCN; the disease is glioblastoma.